May 9, 2019 – May 10, 2019
Washington, District of Columbia, USA
Save the date! HESI DART Committee and European Teratology Society Workshop on Thyroid Hormone Assessment: Implications for Developmental and Reproductive Toxicology
May 8, 2019
Newark, Delaware, USA
Novel in vitro and in vivo assays have been developed to improve the reliability of tools employed for identification of genotoxic hazard. Several of the new assays can provide insight into mode-of-action (MoA). As emerging technologies generally used for evaluating human hazard and/or risk, these novel ...
April 29, 2019
Dr. Ivy Moffat, Health Canada
April 29, 2019, Water Prioritization Webinar. A presentation on "Exposure and Hazard-Driven Prioritization for Evaluation of Chemicals in Canadian Drinking Water" was given by Dr. Ivy Moffat (Health Canada).
April 9, 2019 – April 10, 2019
San Francisco, California, USA
The field of immunotoxicology is a dynamic one in which changing public health concerns, novel biomedical research advances, and innovative technological developments constantly change the landscape and the way in which work is carried out and utilized. As this field requires combined expertise in both immunology and ...
March 29, 2019
Silver Spring, Maryland, USA
FDA Workshop on Leveraging Human-Relevant Cardiomyocytes in Nonclinical Studies to Provide Mechanistic Insights into Cardiovascular Safety Liabilities
WP_Query Object
(
[query] => Array
(
[post_type] => event
[posts_per_page] => 6
[type] =>
[area] =>
[before] => 2025-06-15
[after] =>
[tags] =>
[showtitle] => false
[meta_query] => Array
(
[relation] => Array
(
[0] => AND
[1] => AND
)
[0] => Array
(
[key] => _ilsi_date
[value] => 2025-06-15
[compare] => <=
)
[1] => Array
(
[key] => _ilsi_end_date
[value] => 2025-06-15
[compare] => <=
)
[2] => Array
(
[key] => _ilsi_date
[value] => Array
(
[0] => 2019-01-01
[1] => 2019-12-31
)
[compare] => BETWEEN
)
[3] => Array
(
[key] => _ilsi_date
[value] => 2019-12-31
[compare] => <
)
)
[paged] => 2
[meta_key] => _ilsi_date
[orderby] => meta_value
[order] => DESC
)
[query_vars] => Array
(
[post_type] => event
[posts_per_page] => 6
[type] =>
[area] =>
[before] => 2025-06-15
[after] =>
[tags] =>
[showtitle] => false
[meta_query] => Array
(
[relation] => Array
(
[0] => AND
[1] => AND
)
[0] => Array
(
[key] => _ilsi_date
[value] => 2025-06-15
[compare] => <=
)
[1] => Array
(
[key] => _ilsi_end_date
[value] => 2025-06-15
[compare] => <=
)
[2] => Array
(
[key] => _ilsi_date
[value] => Array
(
[0] => 2019-01-01
[1] => 2019-12-31
)
[compare] => BETWEEN
)
[3] => Array
(
[key] => _ilsi_date
[value] => 2019-12-31
[compare] => <
)
)
[paged] => 2
[meta_key] => _ilsi_date
[orderby] => meta_value
[order] => DESC
[error] =>
[m] =>
[p] => 0
[post_parent] =>
[subpost] =>
[subpost_id] =>
[attachment] =>
[attachment_id] => 0
[name] =>
[pagename] =>
[page_id] => 0
[second] =>
[minute] =>
[hour] =>
[day] => 0
[monthnum] => 0
[year] => 0
[w] => 0
[category_name] =>
[tag] =>
[cat] =>
[tag_id] =>
[author] =>
[author_name] =>
[feed] =>
[tb] =>
[meta_value] =>
[preview] =>
[s] =>
[sentence] =>
[title] =>
[fields] =>
[menu_order] =>
[embed] =>
[category__in] => Array
(
)
[category__not_in] => Array
(
)
[category__and] => Array
(
)
[post__in] => Array
(
)
[post__not_in] => Array
(
)
[post_name__in] => Array
(
)
[tag__in] => Array
(
)
[tag__not_in] => Array
(
)
[tag__and] => Array
(
)
[tag_slug__in] => Array
(
)
[tag_slug__and] => Array
(
)
[post_parent__in] => Array
(
)
[post_parent__not_in] => Array
(
)
[author__in] => Array
(
)
[author__not_in] => Array
(
)
[search_columns] => Array
(
)
[ignore_sticky_posts] =>
[suppress_filters] =>
[cache_results] => 1
[update_post_term_cache] => 1
[update_menu_item_cache] =>
[lazy_load_term_meta] => 1
[update_post_meta_cache] => 1
[nopaging] =>
[comments_per_page] => 50
[no_found_rows] =>
)
[tax_query] => WP_Tax_Query Object
(
[queries] => Array
(
)
[relation] => AND
[table_aliases:protected] => Array
(
)
[queried_terms] => Array
(
)
[primary_table] => wp_posts
[primary_id_column] => ID
)
[meta_query] => WP_Meta_Query Object
(
[queries] => Array
(
[0] => Array
(
[key] => _ilsi_date
)
[1] => Array
(
[0] => Array
(
[key] => _ilsi_date
[value] => 2025-06-15
[compare] => <=
)
[1] => Array
(
[key] => _ilsi_end_date
[value] => 2025-06-15
[compare] => <=
)
[2] => Array
(
[key] => _ilsi_date
[value] => Array
(
[0] => 2019-01-01
[1] => 2019-12-31
)
[compare] => BETWEEN
)
[3] => Array
(
[key] => _ilsi_date
[value] => 2019-12-31
[compare] => <
)
[relation] => AND
)
[relation] => AND
)
[relation] => AND
[meta_table] => wp_postmeta
[meta_id_column] => post_id
[primary_table] => wp_posts
[primary_id_column] => ID
[table_aliases:protected] => Array
(
[0] => wp_postmeta
[1] => mt1
[2] => mt2
[3] => mt3
[4] => mt4
)
[clauses:protected] => Array
(
[wp_postmeta] => Array
(
[key] => _ilsi_date
[compare] => =
[compare_key] => =
[alias] => wp_postmeta
[cast] => CHAR
)
[mt1] => Array
(
[key] => _ilsi_date
[value] => 2025-06-15
[compare] => <=
[compare_key] => =
[alias] => mt1
[cast] => CHAR
)
[mt2] => Array
(
[key] => _ilsi_end_date
[value] => 2025-06-15
[compare] => <=
[compare_key] => =
[alias] => mt2
[cast] => CHAR
)
[mt3] => Array
(
[key] => _ilsi_date
[value] => Array
(
[0] => 2019-01-01
[1] => 2019-12-31
)
[compare] => BETWEEN
[compare_key] => =
[alias] => mt3
[cast] => CHAR
)
[mt4] => Array
(
[key] => _ilsi_date
[value] => 2019-12-31
[compare] => <
[compare_key] => =
[alias] => mt4
[cast] => CHAR
)
)
[has_or_relation:protected] =>
)
[date_query] =>
[request] =>
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID
FROM wp_posts INNER JOIN wp_postmeta ON ( wp_posts.ID = wp_postmeta.post_id ) INNER JOIN wp_postmeta AS mt1 ON ( wp_posts.ID = mt1.post_id ) INNER JOIN wp_postmeta AS mt2 ON ( wp_posts.ID = mt2.post_id ) INNER JOIN wp_postmeta AS mt3 ON ( wp_posts.ID = mt3.post_id ) INNER JOIN wp_postmeta AS mt4 ON ( wp_posts.ID = mt4.post_id )
WHERE 1=1 AND (
wp_postmeta.meta_key = '_ilsi_date'
AND
(
( mt1.meta_key = '_ilsi_date' AND mt1.meta_value <= '2025-06-15' )
AND
( mt2.meta_key = '_ilsi_end_date' AND mt2.meta_value <= '2025-06-15' )
AND
( mt3.meta_key = '_ilsi_date' AND mt3.meta_value BETWEEN '2019-01-01' AND '2019-12-31' )
AND
( mt4.meta_key = '_ilsi_date' AND mt4.meta_value < '2019-12-31' )
)
) AND ((wp_posts.post_type = 'event' AND (wp_posts.post_status = 'publish' OR wp_posts.post_status = 'acf-disabled')))
GROUP BY wp_posts.ID
ORDER BY wp_postmeta.meta_value DESC
LIMIT 6, 6
[posts] => Array
(
[0] => WP_Post Object
(
[ID] => 20795
[post_author] => 2
[post_date] => 2019-01-10 10:45:01
[post_date_gmt] => 2019-01-10 15:45:01
[post_content] =>
Recent updates to OECD developmental/reproductive toxicology guidelines and other regulatory guidelines and guidance require the measurement of thyroid hormone levels in the blood of mammalian laboratory species during development. Preliminary analyses indicate that there is a wide variability across laboratories in the methods being used to measure thyroid hormones in young rodents, as well as in the success of obtaining reliable data. Even though publicly available regulatory guidelines and guidance address study design, they allow varied approaches to thyroid hormone measurement in rodents, and an optimal study design or logical approach to thyroid hormone testing in young rodents has not yet been established in a regulatory testing context. Validity, accuracy, sensitivity and reproducibility of the assays are issues of concern. It is not clear to what extent variability in the data can be attributed to methodological issues or to innate biological variability.
WORKSHOP AIMS
- Present the state-of-the-science on thyroid hormone assessments, specifically as it relates to preclinical methods and data collection, and identify gaps and knowledge as it relates to regulatory DART testing,
- Provide clarification and guidance regarding the collection (timing and methods), assessment (standardization and validation), and interpretation of thyroid hormone data (as it relates to adversity) for regulatory toxicology and risk assessment,
- Discuss and come to consensus on recommendations on how to improve data interpretation/understanding of thyroid changes and their relationship to adverse outcomes
WORKSHOP AGENDA
Click here to download the workshop agenda.
Session 1: Setting the Stage
The Thyroid Axis - Overview of Anatomy, Physiology, Regulation in Mammalian Systems
Mary Gilbert, U.S. EPA (Download presentation)
An AOP Network for Thyroid Hormone Disruption and Adverse Outcomes
Kevin Crofton, R3Fellows, LLC (Download presentation)
Mild Thyroid Dysfunction During Pregnancy; Consequences for Pregnancy Outcome and Fetal Development
Robin Peeters, Erasmus University (Download presentation)
Session 2: Methodologies & Interpretation
Regulatory Requirements for Evaluation of Thyroid Status
Sue Marty, Dow (Download presentation)
Pathology Endpoints: Evaluation of Thyrotoxicants in Animal Studies
Brent Walling, Charles River (Download presentation)
Overview of In Vitro Assays to Investigate Chemicals for Thyroid-Axis Disrupting Potential
Michael Hornung, U.S. EPA (Download presentation)
Session 3: Global Thyroid Activities
Overview of Ongoing Thyroid Activities in the European Union and United States
Manon Beekhuijzen, Charles River (Download presentation)
HESI DART - ETS Thyroid Hormone Survey - Results & the Path Forward
Pragati Coder, Charles River (Download presentation)
[post_title] => HESI DART Committee Thyroid Hormone Assessment Workshop
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => hesi-dart-committee-thyroid-hormone-assessment-workshop
[to_ping] =>
[pinged] =>
[post_modified] => 2020-10-28 14:07:16
[post_modified_gmt] => 2020-10-28 14:07:16
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://hesiglobal.org/?post_type=event&p=20795
[menu_order] => 0
[post_type] => event
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[1] => WP_Post Object
(
[ID] => 21067
[post_author] => 12
[post_date] => 2019-03-26 09:22:27
[post_date_gmt] => 2019-03-26 14:22:27
[post_content] =>
[post_title] => Validation of New Approaches in Genetic Toxicology
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => validation-of-new-approaches-in-genetic-toxicology
[to_ping] =>
[pinged] =>
[post_modified] => 2020-10-28 14:42:06
[post_modified_gmt] => 2020-10-28 14:42:06
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://hesiglobal.org/?post_type=event&p=21067
[menu_order] => 0
[post_type] => event
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 28604
[post_author] => 16
[post_date] => 2024-09-26 11:52:20
[post_date_gmt] => 2024-09-26 11:52:20
[post_content] =>
[post_title] => Exposure and Hazard-Driven Prioritization for Evaluation of Chemicals in Canadian Drinking Water
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => exposure-and-hazard-driven-prioritization-for-evaluation-of-chemicals-in-canadian-drinking-water
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-26 11:52:20
[post_modified_gmt] => 2024-09-26 11:52:20
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://hesiglobal.org/?post_type=event&p=28604
[menu_order] => 0
[post_type] => event
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 20922
[post_author] => 13
[post_date] => 2019-02-05 11:54:03
[post_date_gmt] => 2019-02-05 16:54:03
[post_content] =>
[post_title] => Cancer Immunotherapies: Biology, Therapeutic Approaches, and Immune-Related Safety Assessments
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => cancer-immunotherapies-biology-therapeutic-approaches-and-immune-related-safety-assessments
[to_ping] =>
[pinged] =>
[post_modified] => 2020-10-28 15:01:04
[post_modified_gmt] => 2020-10-28 15:01:04
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://hesiglobal.org/?post_type=event&p=20922
[menu_order] => 0
[post_type] => event
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[4] => WP_Post Object
(
[ID] => 20672
[post_author] => 8
[post_date] => 2018-11-07 15:50:28
[post_date_gmt] => 2018-11-07 20:50:28
[post_content] =>
[post_title] => FDA Cardiac Safety Workshop
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => hesi-cardiac-safety-fda-workshop
[to_ping] =>
[pinged] =>
[post_modified] => 2020-10-28 13:29:18
[post_modified_gmt] => 2020-10-28 13:29:18
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://hesiglobal.org/?post_type=event&p=20672
[menu_order] => 0
[post_type] => event
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 5
[current_post] => -1
[before_loop] =>
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 20795
[post_author] => 2
[post_date] => 2019-01-10 10:45:01
[post_date_gmt] => 2019-01-10 15:45:01
[post_content] =>
Recent updates to OECD developmental/reproductive toxicology guidelines and other regulatory guidelines and guidance require the measurement of thyroid hormone levels in the blood of mammalian laboratory species during development. Preliminary analyses indicate that there is a wide variability across laboratories in the methods being used to measure thyroid hormones in young rodents, as well as in the success of obtaining reliable data. Even though publicly available regulatory guidelines and guidance address study design, they allow varied approaches to thyroid hormone measurement in rodents, and an optimal study design or logical approach to thyroid hormone testing in young rodents has not yet been established in a regulatory testing context. Validity, accuracy, sensitivity and reproducibility of the assays are issues of concern. It is not clear to what extent variability in the data can be attributed to methodological issues or to innate biological variability.
WORKSHOP AIMS
- Present the state-of-the-science on thyroid hormone assessments, specifically as it relates to preclinical methods and data collection, and identify gaps and knowledge as it relates to regulatory DART testing,
- Provide clarification and guidance regarding the collection (timing and methods), assessment (standardization and validation), and interpretation of thyroid hormone data (as it relates to adversity) for regulatory toxicology and risk assessment,
- Discuss and come to consensus on recommendations on how to improve data interpretation/understanding of thyroid changes and their relationship to adverse outcomes
WORKSHOP AGENDA
Click here to download the workshop agenda.
Session 1: Setting the Stage
The Thyroid Axis - Overview of Anatomy, Physiology, Regulation in Mammalian Systems
Mary Gilbert, U.S. EPA (Download presentation)
An AOP Network for Thyroid Hormone Disruption and Adverse Outcomes
Kevin Crofton, R3Fellows, LLC (Download presentation)
Mild Thyroid Dysfunction During Pregnancy; Consequences for Pregnancy Outcome and Fetal Development
Robin Peeters, Erasmus University (Download presentation)
Session 2: Methodologies & Interpretation
Regulatory Requirements for Evaluation of Thyroid Status
Sue Marty, Dow (Download presentation)
Pathology Endpoints: Evaluation of Thyrotoxicants in Animal Studies
Brent Walling, Charles River (Download presentation)
Overview of In Vitro Assays to Investigate Chemicals for Thyroid-Axis Disrupting Potential
Michael Hornung, U.S. EPA (Download presentation)
Session 3: Global Thyroid Activities
Overview of Ongoing Thyroid Activities in the European Union and United States
Manon Beekhuijzen, Charles River (Download presentation)
HESI DART - ETS Thyroid Hormone Survey - Results & the Path Forward
Pragati Coder, Charles River (Download presentation)
[post_title] => HESI DART Committee Thyroid Hormone Assessment Workshop
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => hesi-dart-committee-thyroid-hormone-assessment-workshop
[to_ping] =>
[pinged] =>
[post_modified] => 2020-10-28 14:07:16
[post_modified_gmt] => 2020-10-28 14:07:16
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://hesiglobal.org/?post_type=event&p=20795
[menu_order] => 0
[post_type] => event
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[comment_count] => 0
[current_comment] => -1
[found_posts] => 11
[max_num_pages] => 2
[max_num_comment_pages] => 0
[is_single] =>
[is_preview] =>
[is_page] =>
[is_archive] =>
[is_date] =>
[is_year] =>
[is_month] =>
[is_day] =>
[is_time] =>
[is_author] =>
[is_category] =>
[is_tag] =>
[is_tax] =>
[is_search] =>
[is_feed] =>
[is_comment_feed] =>
[is_trackback] =>
[is_home] => 1
[is_privacy_policy] =>
[is_404] =>
[is_embed] =>
[is_paged] => 1
[is_admin] =>
[is_attachment] =>
[is_singular] =>
[is_robots] =>
[is_favicon] =>
[is_posts_page] =>
[is_post_type_archive] =>
[query_vars_hash:WP_Query:private] => 471aeb84d03f5edc1f4d6618e90155d0
[query_vars_changed:WP_Query:private] =>
[thumbnails_cached] =>
[allow_query_attachment_by_filename:protected] =>
[stopwords:WP_Query:private] =>
[compat_fields:WP_Query:private] => Array
(
[0] => query_vars_hash
[1] => query_vars_changed
)
[compat_methods:WP_Query:private] => Array
(
[0] => init_query_flags
[1] => parse_tax_query
)
)
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.